The Effect of Nintedanib on T-Cell Activation, Subsets and Functions

BACKGROUND: T cells are important regulators of inflammation and, via release of mediators, can contribute to pulmonary fibrosis. Nintedanib is approved for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease (ILD) and chronic fibrosing ILDs with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ubieta, Kenia, Thomas, Matthew James, Wollin, Lutz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954282/
https://www.ncbi.nlm.nih.gov/pubmed/33727792
http://dx.doi.org/10.2147/DDDT.S288369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954282/
https://www.ncbi.nlm.nih.gov/pubmed/33727792
http://dx.doi.org/10.2147/DDDT.S288369

Ejemplares similares